Caspian Capital’s Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 MACC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,666
Closed 19
2022
Q3
$0 Hold
16,666
﹤0.01% 20
2022
Q2
$163K Buy
+16,666
New +$2.57K 0.23% 17

Other funds holding MACC.WS

Caspian Capital's MACC.WS Position: Q4 2022 in Review

Caspian Capital sold out of Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (MACC.WS) in Q4 2022, closing a stake of 16,666 shares.

Caspian Capital first reported a position in MACC.WS in Q2 2022 and held it in 2 quarters. The position peaked at $163K in Q2 2022. 1 fund tracked by Wall St. Rank holds MACC.WS as of Q4 2022.

  • Caspian Capital reported no remaining Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Caspian Capital sold 16,666 Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2022.
  • Caspian Capital first reported a position in Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2022 and held it in 2 quarters.
  • Caspian Capital's Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $163K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on Caspian Capital's 13F filing for Q4 2022, filed 14 Feb 2023.